• CSL Behring to Attend and Sponsor World Federation of Hemophilia First Ever Virtual Summit

    • June 16, 2020
    • Posted By : admin
    • 0 Comment

    Global biotherapeutics leader CSL Behring announced today that the company will both attend and sponsor the World Federation of Hemophilia (WFH) first ever Virtual Summit June 14-19, 2020. WFH is an international not-for-profit organization that works to improve the lives of people with hemophilia and other inherited bleeding disorders, and CSL Behring is proud to be a long-term partner with the WFH to connect the global bleeding disorders community.

    “CSL Behring has been on the forefront of delivering innovative treatments for people with bleeding disorders for many years and today our commitment to address patients’ unmet needs is stronger than ever,” said Antti Kourula, Vice President, Hematology Therapeutic Area, CSL Behring. “We look forward to joining the WFH in this new, virtual format to bring together institutions and individuals committed to ensuring patients receive proper diagnoses, access to care and ongoing support for both themselves and their loved ones.”

    At the WFH virtual summit, CSL Behring will participate in the WFH Highlights session, “Humanitarian Aid Program: Past and Future” on Sunday, June 14 from 11:00 am-12:00 pm EDT and host a symposium titled, “Hemophilia B: Care Across the Spectrum” on Tuesday, June 16 from 12:40-1:40 pm EDT. The virtual symposium will discuss the paradigm shift in hemophilia B management, including the discordant between disease severity and bleeding phenotype and the utility of precision medicine to optimize treatment. CSL Behring will also present two posters:

    • Bleed Rates, Dosing Frequency, and Consumption from a Survey of Japanese Patients Treated Prophylactically with rIX-FP, rFIXFc, or rFIX
    • Heavy Menstrual Bleeding in the Community: Presentation at the Emergency Department

    CSL Behring was the first corporate partner to commit to a multi-year agreement with WFH and, in 2019, announced its fourth multi-year commitment as Visionary Corporate Partner, to advance programs that help improve diagnosis and access to care for patients in developing countries, provide medical training, increase awareness, establish education initiatives and achieve government support through advocacy.


You Might Also Like

No comments found



error: Content is protected !!